Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma

Clinical and Translational Oncology

Volumn 15, Issue 2, 2013, Pages 139-145

  Wang, Liang ^a   Yuan, Jun ^a   Tu, Yanyang ^a   Mao, Xinggang ^b   He, Shiming ^a   Fu, Guoqiang ^a   Zong, Jianhai ^a   Zhang, Yongsheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Chinese PLA 254 Hospital   (China)

Author keywords

Co expression; Glioma; Immunohistochemistry; Matrix metalloproteinase 14; Matrix metalloproteinase 19; Prognosis; Western blot

Indexed keywords

MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 19;

ADOLESCENT; ADULT; ADVANCED CANCER; ADVERSE OUTCOME; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL TIME; TUMOR VOLUME; WESTERN BLOTTING;

EID: 84877763496     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0900-5     Document Type: Article

References (26)

1. Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93
2. Louis DN, Ohgaki H, Wiestler ODl (2007) The 2007 WHO classification of tumors of the central nervous system. Acta Neuropathol 114:97-109
3. Mu YG, Chen MZ, Chen ZP, Zhou WN, Zhang XH, Sai K (2004) Microsurgical technique of brain glioma - a report of 183 cases. Ai Zheng 23:1317-1321
4. O'Hara A, Lim FL, Mazzatti DJ, Trayhurn P (2009) Microarray analysis identifies matrix metalloproteinases (MMPs) as key genes whose expression is up-regulated in human adipocytes by macrophage-conditioned medium. Pflugers Arch 458:1103-1114
5. Murphy G, Knäuper V, Cowell S, Hembry R, Stanton H, Butler G, Freije J, Pendás AM, López-Otín C (1999) Evaluation of some newer matrix metalloproteinases. Ann NY Acad Sci 878:25-39
6. Delassus GS, Cho H, Hoang S, Eliceiri GL (2010) Many new down- and up-regulatory signaling pathways, from known cancer progression suppressors to matrix metalloproteinases, differ widely in cells of various cancers. J Cell Physiol 224:549-558
7. Delassus GS, Cho H, Eliceiri GL (2011) New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells. J Cell Physiol 226:3378-3384
8. Sampieri CL, Nuttall RK, Young DA, Goldspink D, Clark IM, Edwards DR (2008) Activation of p38 and JNK MAPK pathways abrogates requirement for new protein synthesis for phorbol ester mediated induction of select MMP and TIMP genes. Matrix Biol 27:128-138
9. Weng CJ, Chen MK, Lin CW, Chung TT, Yang SF (2011) Single nucleotide polymorphisms and haplotypes of MMP-14 are associated with the risk and pathological development of oral cancer. Ann Surg Oncol (in press)
10. Chen TY, Li YC, Liu YF, Tsai CM, Hsieh YH, Lin CW, Yang SF, Weng CJ (2011) Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma. Ann Surg Oncol 18:2348-2356
11. Kondratiev S, Gnepp DR, Yakirevich E, Sabo E, Annino DJ, Rebeiz E, Laver NV (2008) Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas. Hum Pathol 39:337-343
12. Zarrabi K, Dufour A, Li J, Kuscu C, Pulkoski-Gross A, Zhi J, Hu Y, Sampson NS, Zucker S, Cao J (2011) Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. J Biol Chem 286:33167-33177
13. Xie H, Xue YX, Liu LB, Wang P, Liu YH, Ying HQ (2011) Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades. Med Oncol 28(1):S433-S438
14. Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang J, Wang X, You Y, Yang Z, Liu N (2011) MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res 1389:9-18
15. Pendás AM, Folgueras AR, Llano E, Caterina J, Frerard F, Rodríguez F, Astudillo A, Noel A, Birkedal-Hansen H, López- Otín C (2004) Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice. Mol Cell Biol 24:5304-5313
16. Beck IM, Rückert R, Brandt K, Mueller MS, Sadowski T, Brauer R, Schirmacher P, Mentlein R, Sedlacek R (2008) MMP19 is essential for T cell development and T cell-mediated cutaneous immune responses. PLoS One 3:e2343
17. Zhao S, Zhao Y, Niu P, Wang N, Tang Z, Zan L, Li K (2011) Molecular characterization of porcine MMP19 and MMP23B genes and its association with immune traits. Int J Biol Sci 7:1101-1113
18. Chan KC, Ko JM, Lung HL, Sedlacek R, Zhang ZF, Luo DZ, Feng ZB, Chen S, Chen H, Chan KW, Tsao SW, Chua DT, Zabarovsky ER, Stanbridge EJ, Lung ML (2011) Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. Int J Cancer 129:1826-1837
19. Delassus GS, Cho H, Park J, Eliceiri GL (2008) New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells. J Cell Physiol 17:739-744
20. Lai K, Conway RM, Crouch R, Jager MJ, Madigan MC (2008) Expression and distribution of MMPs and TIMPs in human uveal melanoma. Exp Eye Res 86:936-941
21. Müller M, Beck IM, Gadesmann J, Karschuk N, Paschen A, Proksch E, Djonov V, Reiss K, Sedlacek R (2010) MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells. Mod Pathol 23:511-521
22. Jackson V, Olsson T, Kurtovic S, Folkersen L, Paloschi V, W?gs?ter D, Franco-Cereceda A, Eriksson P. (2011) Matrix metalloproteinase 14 and 19 expression is associated with thoracic aortic aneurysms. J Thorac Cardiovasc Surg. In press
23. Velinov N, Aebersold D, Haeni N, Hlushchuk R, Mishev G, Weinstein F, Sedlacek R, Djonov V (2007) Matrix metalloproteinase-19 is a predictive marker for tumor invasiveness in patients with oropharyngeal squamous cell carcinoma. Int J Biol Markers 22:265-273
24. Jost M, Folgueras AR, Frérart F, Pendas AM, Blacher S, Houard X, Berndt S, Munaut C, Cataldo D, Alvarez J, Melen-Lamalle L, Foidart JM, López-Otín C, Noël A (2006) Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19-deficient mice. Cancer Res 66:5234-5241
25. Stojic J, Hagemann C, Haas S, Herbold C, Kühnel S, Gerngras S, Roggendorf W, Roosen K, Vince GH (2008) Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res 60:40-49
26. Lettau I, Hattermann K, Held-Feindt J, Brauer R, Sedlacek R, Mentlein R (2010) Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells. J Neuropathol Exp Neurol 69:215-223